A new strategy to investigate the toxicity of nanomaterials using Langmuir monolayers as membrane models

Nanotoxicology

Volumn 7, Issue 1, 2013, Pages 61-70

  Cancino, Juliana ^a   Nobre, Thatyane M ^a   Oliveira, Osvaldo N ^a   MacHado, Sergio A S ^a   Zucolotto, Valtencir ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dendrimers; Membrane model; Nanomedicine; Nanotoxicity; SWCNTS

Indexed keywords

DENDRIMER; NANOCONJUGATE; PHOSPHOLIPID; POLYAMIDOAMINE; SINGLE WALLED NANOTUBE;

ADSORPTION KINETICS; ARTICLE; BREWSTER ANGLE MICROSCOPY; CELL MEMBRANE; COMPLEX FORMATION; ISOTHERM; MEMBRANE MODEL; MOLECULAR INTERACTION; NANOENGINEERING; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; ZETA POTENTIAL;

EID: 84872134814     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2011.629748     Document Type: Article

References (57)

1. Albini A, Mussi V, Parodi A, Ventura A, Principi E, Tegami S, et al. 2010. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomed Nanotechnol Biol Med 6(2):277-288.
2. Alencar WS, Crespilho FN, Martins MVA, Zucolotto V, Oliveira ON, Silva WC. 2009. Synergistic interaction between gold nanoparticles and nickel phthalocyanine in layer-by-layer (LbL) films: evidence of constitutional dynamic chemistry (CDC). Phys Chem Chem Phys 11:5086-5091.
3. Baktur R, Patel H, Kwon S. 2011. Effect of exposure conditions on SWCNT-induced inflammatory response in human alveolar epithelial cells. Toxicol In Vitro 25:1153-1160.
4. Boas U, Christensen JB, Heegaard PMH. 2006. Dendrimers in medicine and biotechnology: New Molecular Tools. Hardcover: RSC Publisher. Distribution: Ingram Publisher Services, La Vergne, TN, USA.
5. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann M-C. 2005. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88(2):412-419. (Pubitemid 41672149)
6. Caseli L, Crespilho FN, Nobre TM, Zaniquelli MED, Zucolotto V, Oliveira ON Jr. 2008. Using phospholipid Langmuir and Langmuir- blodgett films as matrix for urease immobilization. J Coll Interf Sci 319(1):100-108.
7. Chen J, Chen S, Zhao X, Kuznetsova LV, Wong SS, Ojima I. 2008. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J Am Chem Soc 130(49):16778-16785.
8. Chou CC, Hsiao HY, Hong QS, Chen CH, Peng YW, Chen HW, et al. 2008. Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nano Lett 8(2):437-445.
9. Colhone MC, Nobre TM, Zaniquelli MED, Stabeli RG, Ciancaglini P. 2009. Ciancaglini, incorporation of antigenic GPI-proteins from Leishmania amazonensis to membrane mimetic systems: influence of DPPC/cholesterol ratio. J Coll Interf Sci 333(1):373-379.
10. Davies JT, Rideal EK. 1963. Interfacial phenomena. New York: Academic Press.
11. Davis SS. 1997. Biomedical applications of nanotech- nology-implications for drug targeting and gene therapy. Trends Biotechnol 15:217- 224. (Pubitemid 27242747)
12. Davoren M, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, et al. 2007. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol in Vitro 21 (3):438-448. (Pubitemid 46453117)
13. Dos Santos DS Jr, Pavinatto FJ, Balogh DT, Misoguti L, Oliveira ON Jr, Mendonça CR. 2004. In situ UV-vis absorbance measurements for langmuir films of poly[4¢-[[2-(methacryloyloxy)-ethyl]ethylamino]- 2-chloro-4- nitroazobenzene] (HPDR13) azopolymer. J Coll Interf Sci 276(1):138-142. (Pubitemid 38822985)
14. Fischer HC, Chan WCW. 2007. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565-571.
15. Firme CP, Bandaru PR. 2009. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomed Nanotechnol Biol Med 6:245-256.
16. Foldvari M, Bagonluri M. 2008. Carbon nanotubes as functional excipients for nanomedicines: II. drug delivery and biocompatibility issues. Nanomed Nanotechnol Biol Med 4:173-182.
17. Fernandez-Lopez S, Kim H-S, Choi EC, Delgado M, Granja JR, Khasanov A, et al. 2001. Antibacterial agents based on the cyclic d,l-peptide architecture. Nature 412:452-455. (Pubitemid 32702711)
18. Gaumet M, Gurny R, Delie F. 2009. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur J Pharm Sci 36(4-5):465-473.
19. Geetha B, Mandal AB. 2000. 2-Dimensional Surface Properties of w-Methoxy Poly(ethyleneglycol) Macromonomer in absence and presence of Stearic Acid and Its interaction with SDS As a function of different mole compositions at various temperatures at air-water interface:thermodynamic studies using Langmuir Film balance (Monolayer) technique. Langmuir 16:3957-3963.
20. Ghadiri MR, Granja JR, Buehler L. 1994. Artificial transmembrane ion channels from self-assembling peptide nanotubes. Nature 369:301-304.
21. Guo L, Von Dem Bussche A, Buechner M, Yan A, Kane AB, Hurt RH. 2008. Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. Small 4 (6):721-727. (Pubitemid 352007131)
22. Hénon S, Meunier J. 1991. Microscope at the Brewster angle: direct observation of first-order phase transitions in monolayers. J Rev Sci Instrum 62:936-939.
23. Hoet PH, Bruske-Hohlfeld I, Salata OV. 2004. Nanoparticles - known and unknown health risks. J Nanobiotech 2:12-27.
24. Höning D, Möbius DJ. 1991. Direct visualization of monolayers at the air-water interface by Brewster Angle Microscopy. J Phys Chem 95:4590-4592.
25. Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, et al. 2006. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chem 17(3):728-734. (Pubitemid 43794383)
26. Jain AK, Mehra NK, Lodhi N, Dubey V, Mishra DK, Jain PK, et al. 2007. Carbon nanotubes and their toxicity. Nanotoxicology 1(3):167-197. (Pubitemid 350179073)
27. Ji S, Liu C, Zhang B, Yang F, Xu J, Long J, et al. 2010. Carbon nanotubes in cancer diagnosis and therapy. Biochim Biophys Acta 1806(1):29-35.
28. Kawasaki ES, Player A. 2005. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomed Nanotechnol Biol Med 1:101-109. (Pubitemid 43963616)
29. Kim B, Sigmund WM. 2004. Functionalized multiwall carbon nanotube/ gold nanoparticle composites. Langmuir 20(19):8239-8242.
30. Kulamarva A, Bhathena J, Malhotra M, Sebak S, Nalamasu O, Ajayan P, et al. 2008. In vitro cytotoxicity of functionalized single walled carbon nanotubes for targeted gene delivery applications. Nanotoxicology 2(4):184-188. (Pubitemid 352790868)
31. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. 2011. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810:361-373.
32. Lorite GS, Nobre TM, Zaniquelli MED, de Paula E, Cotta MA. 2009. Dibucaine effects on structural and elastic properties of lipid bilayers. Biophys Chem 139:75-83.
33. Lopes JLS, Nobre TM, Siano A, Humpola V, Bossolan NR, Zaniquelli MED, et al. 2009. Disruption of Saccharomyces cerevisiae by Plantaricin 149 and investigation of its mechanism of action with biomembrane model systems. Biochim Biophys Acta 1788 (10):2252-2258.
34. Mahmood M, Casciano DA, Mocan T, Iancu C, Xu Y, Mocan L, et al. 2010. Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines. J Appl Toxicol 30. 74-83.
35. Marsh D. 1996. Lateral pressure in membranes. Biochim Biophys Acta 1286:183-223. (Pubitemid 26426521)
36. Mandal A, Krishnan RSG, Thennarasu S, Panigrahi S, Mandal AB. 2010. Two-dimensional surface properties of an antimicrobial hydantoin at the air-water interface: An experimental and theoretical study. Colloids Surf B Biointerfaces 79:136-141.
37. Mecke A, Majoros IJ, Patri AK, Baker JR, Holl MM, Orr BG. 2005. Lipid Bilayer Disruption by polycationic polymers: the roles of size and chemical functional group. Langmuir 21(23):10348-10354. (Pubitemid 41692105)
38. Monteiro-Riviere NA, Inman AO. 2006. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44:1070-1078. (Pubitemid 43202164)
39. Nobre TM, Pavinatto FJ, Cominetti MR, Selistre de-Araújo HS, Zaniquelli MED, Beltramini LM. 2010. The specificity of frutalin lectin using biomembrane models. Biochim Biophys Acta 1798:1547-1555.
40. Nobre TM, Wong K, Zaniquelli MED. 2007. Equilibrium and dynamic aspects of dodecyltrimethylammonium bromide adsorption at the air/water interface in the presence of l-carrageenan. J Coll Interf Sci 305(1):142-149. (Pubitemid 44767889)
41. Nyitrai G, Kékesi O, Pál I, Keglevich P, Csíki Z, Fügedi P, et al. 2011. Assessing toxicity of polyamidoamine dendrimers by neuronal signaling functions. Nanotoxicology; posted on line on June 20.
42. Oberdörster G, Stone V, Donaldson K. 2007. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1(1):2-25. (Pubitemid 46570244)
43. Pavinatto FJ, Caseli L, Pavinatto A, dos Santos DS Jr, Nobre TM, Zaniquelli MED, et al. 2007. Probing chitosan and phospholipid interactions using Langmuir and Langmuir-blodgett films as cell membrane models. Langmuir 23(14):7666-7671. (Pubitemid 47116431)
44. Peetla C, Labhasetwar V. 2007. Biophysical characterization of nanoparticle endothelial model cell membrane interactions. Mol Pharmaceutics 5(3):418-429.
45. Roiter Y, Ornatska M, Rammohan AR, Balakrishnan J, Heine DR, Minko S. 2009. Interaction of lipid membrane with nanostructured surfaces. Langmuir 25(11):6287-6299.
46. Sahoo SK, Parveen S, Panda JJ. 2007. The present and future of nanotechnology in human health care. Nanomed Nanotechnol Biol Med 3:20-31. (Pubitemid 46428187)
47. Sargent LM, Reynolds SH, Castranova V. 2010. Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects. Nanotoxicology 4:(4)396-408.
48. Siqueira JR, Abouzar MH, Poghossian A, Zucolotto V, Oliveira ON, Schoning M. 2009. Penicillin biosensor based on a capacitive field- effect structure functionalized with a dendrimer/carbon nanotube multilayer. Biosens Bioelectron 25(2):497-501.
49. Siqueira JR, Gasparotto LHS, Oliveira ON, Zucolotto V. 2008. Processing of electroactive nanostructured films incorporating carbon nanotubes and phthalocyanines for sensing. J Phys Chem C 112 (24):9050-9055.
50. Sun L, Warren GL, O'Reilly JY, Everett WN, Lee SM, Davis D, et al. 2008. Mechanical properties of surface-functionalized SWCNT/epoxy composites. Carbon 46:320-328.
51. Svenson S, Chauhan AS. 2008. Dendrimers for enhanced drug solubilization. Nanomedicine 3(5):679-702.
52. Tabata Y, Ikada Y. 1988. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 9:356-362.
53. Unfried K, Albrecht C, Klotz L, Von Mikecz A, Grether-Beck S, Schins RPF. 2007. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1(1):52-71. (Pubitemid 46570247)
54. Williams D. 2005. The risks of nanotechnology. Med Device Technol 16(9):9-10.
55. Wilkinson JM. 2003. Nanotechnology applications in medicine. Med Device Technol 14:29-31.
56. Yang K, Qin W, Tang H, Tan L, Xie Q, Ma M, et al. 2011. Polyamidoamine dendrimer-functionalized carbon nanotubes-mediates GFP gene transfection for HeLa cells: effect of different types of carbon nanotubes. J Biomed Mater Res Part A 99A:231-239.
57. Zeng YL, Huang YF, Jiang JH, Zhang XB, Tang CR, Shen GL, et al. 2007. Functionalization of multi-walled carbon nanotubes with poly(amidoamine) dendrimer for mediator-free glucose biosensor. Electrochem Commun 9(1):185-190.